Literature DB >> 27768047

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis.

Jürgen Keller1, Martin Gorges1, Helena E A Aho-Özhan1, Ingo Uttner1, Erich Schneider2, Jan Kassubek1, Elmar H Pinkhardt1, Albert C Ludolph1, Dorothée Lulé3.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with pathological involvement of upper and lower motoneurons, subsequently leading to progressive loss of motor and speech abilities. In addition, cognitive functions are impaired in a subset of patients. To evaluate these potential deficits in severely physically impaired ALS patients, eye-tracking is a promising means to conduct cognitive tests. The present article focuses on how eye movements, an indirect means of communication for physically disabled patients, can be utilized to allow for detailed neuropsychological assessment. The requirements, in terms of oculomotor parameters that have to be met for sufficient eye-tracking in ALS patients are presented. The properties of stimuli, including type of neuropsychological tests and style of presentation, best suited to successfully assess cognitive functioning, are also described. Furthermore, recommendations regarding procedural requirements are provided. Overall, this methodology provides a reliable, easy to administer and fast approach for assessing cognitive deficits in patients who are unable to speak or write such as patients with severe ALS. The only confounding factor might be deficits in voluntary eye movement control in a subset of ALS patients.

Entities:  

Mesh:

Year:  2016        PMID: 27768047      PMCID: PMC5092192          DOI: 10.3791/54634

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  23 in total

Review 1.  End-of-life management in patients with amyotrophic lateral sclerosis.

Authors:  Sheelah Connolly; Miriam Galvin; Orla Hardiman
Journal:  Lancet Neurol       Date:  2015-02-27       Impact factor: 44.182

2.  Cognitive function in patients with late stage amyotrophic lateral sclerosis.

Authors:  J Lakerveld; B Kotchoubey; A Kübler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05-22       Impact factor: 10.154

3.  The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population.

Authors:  Dorothée Lulé; Christian Burkhardt; Susanne Abdulla; Sarah Böhm; Katja Kollewe; Ingo Uttner; Sharon Abrahams; Thomas H Bak; Susanne Petri; Markus Weber; Albert C Ludolph
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-10-08       Impact factor: 4.092

4.  Cognitive deterioration and functional compensation in ALS measured with fMRI using an inhibitory task.

Authors:  Kelsey Witiuk; Juan Fernandez-Ruiz; Ryan McKee; Nadia Alahyane; Brian C Coe; Michel Melanson; Douglas P Munoz
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

5.  Development of ophthalmoplegia in amyotrophic lateral sclerosis during long-term use of respirators.

Authors:  T Mizutani; M Aki; R Shiozawa; M Unakami; T Nozawa; K Yajima; H Tanabe; M Hara
Journal:  J Neurol Sci       Date:  1990-11       Impact factor: 3.181

Review 6.  Decisional Capacity in Amyotrophic Lateral Sclerosis.

Authors:  Eindra Khin Khin; Darlinda Minor; Amanda Holloway; Ayla Pelleg
Journal:  J Am Acad Psychiatry Law       Date:  2015-06

7.  Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life.

Authors:  A Chiò; A Vignola; E Mastro; A Dei Giudici; B Iazzolino; A Calvo; C Moglia; A Montuschi
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

Review 8.  The cognitive profile of ALS: a systematic review and meta-analysis update.

Authors:  Emma Beeldman; Joost Raaphorst; Michelle Klein Twennaar; Marianne de Visser; Ben A Schmand; Rob J de Haan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-08-17       Impact factor: 10.154

9.  EyeSeeCam: an eye movement-driven head camera for the examination of natural visual exploration.

Authors:  Erich Schneider; Thomas Villgrattner; Johannes Vockeroth; Klaus Bartl; Stefan Kohlbecher; Stanislavs Bardins; Heinz Ulbrich; Thomas Brandt
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

10.  Cognitive changes predict functional decline in ALS: a population-based longitudinal study.

Authors:  Marwa Elamin; Peter Bede; Susan Byrne; Norah Jordan; Laura Gallagher; Brona Wynne; Caoimhe O'Brien; Julie Phukan; Catherine Lynch; Niall Pender; Orla Hardiman
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

View more
  3 in total

1.  An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS.

Authors:  Barbara Poletti; Laura Carelli; Federica Solca; Annalisa Lafronza; Elisa Pedroli; Andrea Faini; Nicola Ticozzi; Andrea Ciammola; Paolo Meriggi; Pietro Cipresso; Dorothée Lulé; Albert C Ludolph; Giuseppe Riva; Vincenzo Silani
Journal:  J Neurol       Date:  2017-05-13       Impact factor: 4.849

2.  The Arrows and Colors Cognitive Test (ACCT): A new verbal-motor free cognitive measure for executive functions in ALS.

Authors:  Barbara Poletti; Laura Carelli; Andrea Faini; Federica Solca; Paolo Meriggi; Annalisa Lafronza; Luciana Ciringione; Elisa Pedroli; Nicola Ticozzi; Andrea Ciammola; Pietro Cipresso; Giuseppe Riva; Vincenzo Silani
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

Review 3.  Structural and Functional Brain Mapping Correlates of Impaired Eye Movement Control in Parkinsonian Syndromes: A Systems-Based Concept.

Authors:  Martin Gorges; Hans-Peter Müller; Jan Kassubek
Journal:  Front Neurol       Date:  2018-05-07       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.